India’s Cipla Q3 profit tops estimates on North America sales boost
BENGALURU/HYDERABAD (Reuters) -Indian generic drugmaker Cipla on Monday reported its third-quarter profit above analysts expectations, boosted by strong performances in North American and domestic markets. Consolidated net profit rose 32% to 10.56 billion Indian rupees ($127.1 million) in the quarter ended Dec. 31 from a year earlier, compared with average analysts’ estimate of 10.43 billion …
India’s Cipla Q3 profit tops estimates on North America sales boost Read More »